However, treatment of tumor cells with these agents can also lead to activation of Akt, the most important mTORC2 downstream target, via phosphorylation of Akt at serin 473, in a mTORC2/Rictor dependent manner [36,37]. The gene discussed is AKT1; the disease is neoplasm.